3341 Stock Overview
NIHON CHOUZAI Co.,Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
NIHON CHOUZAI Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,524.00 |
| 52 Week High | JP¥1,690.00 |
| 52 Week Low | JP¥1,080.00 |
| Beta | 0.16 |
| 1 Month Change | -4.51% |
| 3 Month Change | 9.96% |
| 1 Year Change | 27.96% |
| 3 Year Change | -12.11% |
| 5 Year Change | -22.93% |
| Change since IPO | 62.99% |
Recent News & Updates
Shareholder Returns
| 3341 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | -1.6% | -4.7% | -2.2% |
| 1Y | 28.0% | 10.6% | 29.7% |
Return vs Industry: 3341 exceeded the JP Consumer Retailing industry which returned 10.6% over the past year.
Return vs Market: 3341 underperformed the JP Market which returned 29.7% over the past year.
Price Volatility
| 3341 volatility | |
|---|---|
| 3341 Average Weekly Movement | 3.8% |
| Consumer Retailing Industry Average Movement | 3.6% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in JP Market | 8.3% |
| 10% least volatile stocks in JP Market | 2.2% |
Stable Share Price: 3341 has not had significant price volatility in the past 3 months.
Volatility Over Time: 3341's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 5,689 | Yosuke Mitsuhara | www.nicho.co.jp |
NIHON CHOUZAI Co.,Ltd. engages in the management of health insurance dispensing chain pharmacies in Japan. It operates through dispensing pharmacy, pharmaceutical manufacturing and sales, and medical staff dispatching and referral business segments.
NIHON CHOUZAI Co.,Ltd. Fundamentals Summary
| 3341 fundamental statistics | |
|---|---|
| Market cap | JP¥45.77b |
| Earnings (TTM) | JP¥3.94b |
| Revenue (TTM) | JP¥334.60b |
11.6x
P/E Ratio0.1x
P/S RatioIs 3341 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3341 income statement (TTM) | |
|---|---|
| Revenue | JP¥334.60b |
| Cost of Revenue | JP¥278.76b |
| Gross Profit | JP¥55.85b |
| Other Expenses | JP¥51.91b |
| Earnings | JP¥3.94b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 131.63 |
| Gross Margin | 16.69% |
| Net Profit Margin | 1.18% |
| Debt/Equity Ratio | 87.9% |
How did 3341 perform over the long term?
See historical performance and comparison